Last updated on June 2019

Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis


Brief description of study

To demonstrate the safety of 1% OPA-15406 ointment in adult patients with AD and of 0.3% and 1% OPA-15406 ointments in pediatric patients with AD administered twice daily for 52 weeks.

Clinical Study Identifier: NCT03961529

Find a site near you

Start Over
Sorry. There are no research sites conducting this study in the radius provided. ( View all Sites )
If you would like to be informed of other studies that may be of interest to you, you may sign up for CenterWatch.com's Patient Notification Service. ( Sign Up )